Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05951777 · ClinicalTrials.gov registry record · Phase 2

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

A Phase 2 study of Traumatic Brain Injury, sponsored by Hope Biosciences.

Recruiting
Registry status
Phase 2
Development phase
51
Enrollment target
2
Study locations

NCT05951777 is a Phase 2 study of Traumatic Brain Injury that is actively recruiting participants, run by Hope Biosciences. The registered enrollment target is 51 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05951777, a Phase 2 study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Hope Biosciences.

RECRUITING
Registry status
Phase 2
Development phase
51 participants
Enrollment target
2
Study locations

Study Summary

The global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflammation after traumatic brain injury.

Conditions Studied

Traumatic Brain Injury

Interventions

  • DRUG Normal Saline
  • BIOLOGICAL Autologous HB-adMSCs

Study Locations (2)

Texas

  • Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston - Houston
  • The University of Texas Health Science at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2024-04-16
Est. Completion 2026-12
Phase Phase 2

Sponsor

Hope Biosciences

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05951777

The ClinicalTrials.gov registry entry for NCT05951777 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% lower). The listed sponsor is Hope Biosciences, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.

NCT05951777 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05951777 about?

NCT05951777 is a clinical study titled "Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury". The global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflammation after traumatic...

What is the current status of trial NCT05951777?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2024-04-16. Estimated completion is 2026-12.

What conditions does trial NCT05951777 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT05951777?

The interventions under investigation include: Normal Saline (DRUG), Autologous HB-adMSCs (BIOLOGICAL).

Who is sponsoring clinical trial NCT05951777?

This trial is sponsored by Hope Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05951777 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.